Previous studies demonstrated that BRD4-NUT megadomains overlap at oncogenic loci and induce abnormal expression of oncogenes (e.g. MYC, CCAT1 and TP63) in NMC [4]. Here, BRD4 is linked to nut midline carcinoma.